Fresenius Medical Care Corporate Education Session - Vol. 2

Monday, 20 September 2010, 11.00 - 12.30, Auditorium

New aspects of an optimized drug therapy for dialysis patients
Fresenius Medical Care

Detailed overview TBD.

FMC2-inv Download invitation in PDF

Calcium/magnesium-based phosphate binders - a new approach in hyperphosphatemia therapy
Angel LM de Francisco, Santander, Spain

Optimising iron therapy in haemodialysis patients
Cathy Johnson, Derby, UK

Potassium control beyond dialysis: crucial for best practice?
Jacques Rottmbourg, Paris, France

Chairs: Angel LM de Francisco, Paula Ormandy


InterpretationFresenius Medical Care CES will be
simultaneously translated to Czech apart from other languages.